参一胶囊抗血栓作用分析及分子机制预测

陈麒羽 ,  游洪 ,  张大威 ,  刘芬

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 287 -294.

PDF (3086KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 287 -294. DOI: 10.3969/j.issn.1674-7593.2026.06.013
论著

参一胶囊抗血栓作用分析及分子机制预测

作者信息 +

Analysis of the antithrombotic effects of the Shenyi Capsule and prediction of its molecular mechanism

Author information +
文章历史 +
PDF (3159K)

摘要

目的 观察参一胶囊的体内外抗凝血活性和体外二磷酸腺苷 (ADP) 诱导的血小板聚集活性的差异, 并初步探究其抗凝作用的分子机制。方法 将小鼠、大鼠各随机分为四组: 溶剂对照组, 阿司匹林组, 参一胶囊低剂量组, 参一胶囊高剂量组, 每组各 10 只。给药 4 d 后, 通过观察大鼠体外血栓形成、小鼠凝血时间和小鼠尾出血时间评估参一胶囊的抗凝效果, 以 ADP 为诱导剂, 体外测定参一胶囊对血小板聚集的抑制率。利用网络药理学方法和分子对接技术, 探讨参一胶囊发挥抗凝作用的潜在靶点。结果 与溶剂对照组比较, 参一胶囊可抑制大鼠体外血栓形成, 延长小鼠凝血、出血时间, 降低血小板聚集率, 具有剂量依赖性, 且高浓度的参一胶囊的效果优于阿司匹林。网络药理学分析结果显示, 参一胶囊活性成分 20(R)-Rg3 参与调控细胞凋亡信号通路。分子对接结果显示, 20(R)-Rg3 可能与胱天蛋白酶 3、AKT 丝氨酸/苏氨酸激酶 1、沉默信息调节因子 1、自噬相关基因 1、B 细胞淋巴瘤 2 自发形成结合。结论 参一胶囊体内外抗凝作用具有剂量依赖性, 其作用机制可能与细胞凋亡信号通路相关。

Abstract

Objective To compare the anti-coagulant activity of Shenyi capsule in vivo and in vitro, as well as its inhibitory effect on ADP-induced platelet aggregation in vitro, and to preliminarily explore the molecular mechanism underlying its anti-coagulant action. Methods Mice and rats were randomly divided into four groups (10 per group): solvent control group, aspirin group, Shenyi capsule low-dose group, Shenyi capsule high-dose group. After 4 d of administration, the anti-coagulant effects of Shenyi capsule were evaluated by measuring rat thrombosis in vitro, mouse coagulation time, and mouse tail bleeding time. The inhibition rate of Shenyi capsule on platelet aggregation was determined in vitro using ADP as an inducer. Network pharmacology and molecular docking techniques were employed to investigate the potential targets of the Shenyi capsule in exerting its anti-coagulant effects. Results Compared with the solvent control group, Shenyi capsule inhibited thrombosis in vitro in rats, prolonged coagulation and bleeding times in mice, and reduced platelet aggregation rate in a dose-dependent manner. The effects of high-concentration Shenyi capsule were superior to those of aspirin. Network pharmacology analysis indicated that the active ingredient of Shenyi Capsule, 20(R)-Rg3, is involved in the regulation of the apoptosis signaling pathway. Molecular docking results further demonstrated that 20(R)-Rg3 could potentially form spontaneous binding with key apoptosis-related targets, including caspase 3, Akt serine/threonine kinase 1, sirtuin 1, and B-cell lymphoma 2. Conclusion Shenyi capsule exhibits dose-dependent anticoagulant effects both in vitro and in vivo, and its underlying mechanism is likely associated with the modulation of the apoptosis signaling pathway.

关键词

人参皂苷 Rg3 / 20(R)-Rg3 / 抗凝血活性 / 血小板聚集 / 细胞凋亡

Key words

Ginsenoside Rg3 / 20(R)-Rg3 / Anti-coagulation activity / Platelet aggregation / Apoptosis

引用本文

引用格式 ▾
陈麒羽,游洪,张大威,刘芬. 参一胶囊抗血栓作用分析及分子机制预测[J]. 国际老年医学杂志, 2026, 47(6): 287-294 DOI:10.3969/j.issn.1674-7593.2026.06.013

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Liu H, Lu X, Hu Y, et al. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy[J]. Pharmacol Res, 2020, 161: 105263.

[2]

Nakhjavani M, Smith E, Townsend A R, et al. Anti-angiogenic properties of Ginsenoside Rg3[J]. Molecules, 2020, 25(21): 4905.

[3]

Pan L, Zhang T, Sun H, et al. Ginsenoside Rg3 (Shenyi Capsule) combined with chemotherapy for digestive system cancer in China: a meta-analysis and systematic review[J]. Evid Based Complement Alternat Med, 2019, 2019: 2417418.

[4]

GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet Neurol, 2024, 23(10): 973-1003.

[5]

Fu E L, Desai R J, Paik J M, et al. Comparative safety and effectiveness of warfarin or rivaroxaban versus apixaban in patients with advanced CKD and atrial fibrillation: nationwide US cohort study[J]. Am J Kidney Dis, 2024, 83(3): 293-305. e1.

[6]

Siguret V, Gouin-Thibault I, Gaussem P, et al. Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderly[J]. Drugs Aging, 2013, 30(9): 687-699.

[7]

刘芬, 王秋静, 刘洁, 等. 人参二醇皂苷对急性血瘀大鼠肠系膜微循环和血栓形成的影响[J]. 中国老年学杂志, 2008, 28(9): 854-855.

[8]

Liu F, Wang Q J, Liu J, et al. The effect of PDS on acute blood stasis mesenterium microcirculation and thrombogenesis in rats[J]. Chin J Gerontol, 2008, 28(9): 854-855.

[9]

Yang M, Tu Y, Feng K, et al. A erythrocyte-platelet hybrid membrane coated biomimetic nanosystem based on Ginsenosides and PFH combined with ultrasound for targeted delivery in thrombus therapy[J]. Colloids Surf B Biointerfaces, 2023, 229: 113468.

[10]

Gou D, Pei X, Wang J, et al. Antiarrhythmic effects of Ginsenoside Rg2 on calcium chloride-induced arrhythmias without oral toxicity[J]. J Ginseng Res, 2020, 44(5): 717-724.

[11]

王辉, 刘刚, 罗顺德. 莲心碱对血小板聚集、凝血功能和血栓形成的影响[J]. 中国药理学通报, 2010, 26(6): 768-772.

[12]

Wang H, Liu G, Luo S D. Effects of liensinine on platelet aggregation and coagulability and thrombotic activity[J]. Chin Pharmacol Bull, 2010, 26(6): 768-772.

[13]

彭茗, 张瑱, 张彤, 等. 手性人参皂苷 Rg3 的抗凝血和抗血小板聚集活性差异研究[J]. 中华中医药学刊, 2015, 33(9): 2072-2075.

[14]

Peng M, Zhang Z, Zhang T, et al. Research of Stereospecific anti-coagulation and anti-platelet aggregation activities of chiral Ginsenoside Rg3[J]. Chin Arch Tradit Chin Med, 2015, 33(9): 2072-2075.

[15]

杨娟. 延胡索乙素抗血栓作用及机制研究[D]. 郑州: 郑州大学, 2013.

[16]

Yang J. Study on the antithrombotic effect and mechanism of tetrahydropalmatine[D]. Zhengzhou: Zhengzhou University, 2013.

[17]

Konieczyńska M, Natorska J, Undas A . Thrombosis and aging: fibrin clot properties and oxidative stress[J]. Antioxid Redox Signal, 2024, 41(4-6): 233-254.

[18]

Shaikh S B, Balaya R D A, Dagamajalu S, et al. A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence[J]. Cell Commun Signal, 2024, 22(1): 544.

[19]

张立晶, 刘用. 抗栓药物进展[J]. 中国临床医生杂志, 2019, 47(4): 393-397.

[20]

Zhang L J, Liu Y. Progress in antithrombotic drugs[J]. Chin J Clinicians, 2019, 47(4): 393-397.

[21]

De Vriese A S, Caluwé R, Van Der Meersch H, et al. Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial[J]. J Am Soc Nephrol, 2021, 32(6): 1474-1483.

[22]

CRISTAL Study Group. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial[J]. JAMA, 2022, 328(8): 719-727.

[23]

Chaudhary R, Singh A, Chaudhary R, et al. Evaluation of direct oral anticoagulant reversal agents in intracranial hemorrhage: a systematic review and meta-analysis[J]. JAMA Netw Open, 2022, 5(11): e2240145.

[24]

吴柯, 张正雨, 王秋玲, 等. 中药防治肠缺血再灌注损伤研究进展[J]. 世界科学技术-中医药现代化, 2025, 27(7): 1801-1814.

[25]

Wu K, Zhang Z Y, Wang Q L, et al. Research progress in the prevention and treatment of intestinal ischemia-reperfusion injury with Traditional Chinese Medicine[J]. World Sci Technol Mod Tradit Chin Med, 2025, 27(7): 1801-1814.

[26]

孔洋洋, 袁红霞. 《神农本草经》与经方应用之人参篇[J]. 山东中医药大学学报, 2023, 47(2): 127-131.

[27]

Kong Y Y, Yuan H X. Renshen (Ginseng Radix Et Rhizoma) in the Shennong's Classic of Materia Medica and classical formulas[J]. J Shandong Univ Tradit Chin Med, 2023, 47(2): 127-131.

[28]

Yao Z, Zhu H . Pharmacological mechanisms and drug delivery systems of Ginsenoside Rg3: a comprehensive review[J]. Pharmacol Res, 2025, 216: 107799.

[29]

Nakhjavani M, Hardingham J E, Palethorpe H M, et al. Ginsenoside Rg3: potential molecular targets and therapeutic indication in metastatic breast cancer[J]. Medicines (Basel), 2019, 6(1): 17.

[30]

Lee H, Kong G, Tran Q, et al. Relationship between Ginsenoside Rg3 and metabolic syndrome[J]. Front Pharmacol, 2020, 11: 130.

[31]

Geng J, Fu W, Yu X, et al. Ginsenoside Rg3 alleviates ox-LDL induced endothelial dysfunction and prevents atherosclerosis in ApoE-/- mice by regulating PPARγ/FAK signaling pathway[J]. Front Pharmacol, 2020, 11: 500.

[32]

Duan H, Zhang Q, Liu J, et al. Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis[J]. Pharmacol Res, 2021, 168: 105599.

[33]

Dolmatova E V, Wang K, Mandavilli R, et al. The effects of sepsis on endothelium and clinical implications[J]. Cardiovasc Res, 2021, 117(1): 60-73.

AI Summary AI Mindmap
PDF (3086KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉